Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile.
Date
2014
Type:
Artículo
item.page.extent
3
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
Intra-arterial chemotherapy (IAC) has proved to be an effective treatment for retinoblastoma, but can be very expensive in developing countries. We report 2 patients from Chile in whom IAC resulted in globe salvation. Both patients had their medical care provided by the public health system and had failed standard therapy.
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
J AAPOS. 2014 Dec;18(6) p:617-619
Keywords
Antineoplastic Combined Chemotherapy Protocols/economics, Cost-Benefit Analysis, Infusions, Intra-Arterial/economics, Retinoblastoma/drug therapy, Retinal Neoplasms/drug therapy